table of content
1 Introduction to Research & Analysis Reports
1.1 Passive Transdermal Drug Delivery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Passive Transdermal Drug Delivery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Passive Transdermal Drug Delivery Overall Market Size
2.1 Global Passive Transdermal Drug Delivery Market Size: 2021 VS 2028
2.2 Global Passive Transdermal Drug Delivery Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Passive Transdermal Drug Delivery Sales: 2017-2028
3 Company Landscape
3.1 Top Passive Transdermal Drug Delivery Players in Global Market
3.2 Top Global Passive Transdermal Drug Delivery Companies Ranked by Revenue
3.3 Global Passive Transdermal Drug Delivery Revenue by Companies
3.4 Global Passive Transdermal Drug Delivery Sales by Companies
3.5 Global Passive Transdermal Drug Delivery Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Passive Transdermal Drug Delivery Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Passive Transdermal Drug Delivery Product Type
3.8 Tier 1, Tier 2 and Tier 3 Passive Transdermal Drug Delivery Players in Global Market
3.8.1 List of Global Tier 1 Passive Transdermal Drug Delivery Companies
3.8.2 List of Global Tier 2 and Tier 3 Passive Transdermal Drug Delivery Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Passive Transdermal Drug Delivery Market Size Markets, 2021 & 2028
4.1.2 Microfluidics
4.1.3 Smart Pill Technology (SPT)
4.2 By Type - Global Passive Transdermal Drug Delivery Revenue & Forecasts
4.2.1 By Type - Global Passive Transdermal Drug Delivery Revenue, 2017-2022
4.2.2 By Type - Global Passive Transdermal Drug Delivery Revenue, 2023-2028
4.2.3 By Type - Global Passive Transdermal Drug Delivery Revenue Market Share, 2017-2028
4.3 By Type - Global Passive Transdermal Drug Delivery Sales & Forecasts
4.3.1 By Type - Global Passive Transdermal Drug Delivery Sales, 2017-2022
4.3.2 By Type - Global Passive Transdermal Drug Delivery Sales, 2023-2028
4.3.3 By Type - Global Passive Transdermal Drug Delivery Sales Market Share, 2017-2028
4.4 By Type - Global Passive Transdermal Drug Delivery Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Passive Transdermal Drug Delivery Market Size, 2021 & 2028
5.1.2 Clinic
5.1.3 Hospital
5.1.4 Others
5.2 By Application - Global Passive Transdermal Drug Delivery Revenue & Forecasts
5.2.1 By Application - Global Passive Transdermal Drug Delivery Revenue, 2017-2022
5.2.2 By Application - Global Passive Transdermal Drug Delivery Revenue, 2023-2028
5.2.3 By Application - Global Passive Transdermal Drug Delivery Revenue Market Share, 2017-2028
5.3 By Application - Global Passive Transdermal Drug Delivery Sales & Forecasts
5.3.1 By Application - Global Passive Transdermal Drug Delivery Sales, 2017-2022
5.3.2 By Application - Global Passive Transdermal Drug Delivery Sales, 2023-2028
5.3.3 By Application - Global Passive Transdermal Drug Delivery Sales Market Share, 2017-2028
5.4 By Application - Global Passive Transdermal Drug Delivery Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Passive Transdermal Drug Delivery Market Size, 2021 & 2028
6.2 By Region - Global Passive Transdermal Drug Delivery Revenue & Forecasts
6.2.1 By Region - Global Passive Transdermal Drug Delivery Revenue, 2017-2022
6.2.2 By Region - Global Passive Transdermal Drug Delivery Revenue, 2023-2028
6.2.3 By Region - Global Passive Transdermal Drug Delivery Revenue Market Share, 2017-2028
6.3 By Region - Global Passive Transdermal Drug Delivery Sales & Forecasts
6.3.1 By Region - Global Passive Transdermal Drug Delivery Sales, 2017-2022
6.3.2 By Region - Global Passive Transdermal Drug Delivery Sales, 2023-2028
6.3.3 By Region - Global Passive Transdermal Drug Delivery Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Passive Transdermal Drug Delivery Revenue, 2017-2028
6.4.2 By Country - North America Passive Transdermal Drug Delivery Sales, 2017-2028
6.4.3 US Passive Transdermal Drug Delivery Market Size, 2017-2028
6.4.4 Canada Passive Transdermal Drug Delivery Market Size, 2017-2028
6.4.5 Mexico Passive Transdermal Drug Delivery Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Passive Transdermal Drug Delivery Revenue, 2017-2028
6.5.2 By Country - Europe Passive Transdermal Drug Delivery Sales, 2017-2028
6.5.3 Germany Passive Transdermal Drug Delivery Market Size, 2017-2028
6.5.4 France Passive Transdermal Drug Delivery Market Size, 2017-2028
6.5.5 U.K. Passive Transdermal Drug Delivery Market Size, 2017-2028
6.5.6 Italy Passive Transdermal Drug Delivery Market Size, 2017-2028
6.5.7 Russia Passive Transdermal Drug Delivery Market Size, 2017-2028
6.5.8 Nordic Countries Passive Transdermal Drug Delivery Market Size, 2017-2028
6.5.9 Benelux Passive Transdermal Drug Delivery Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Passive Transdermal Drug Delivery Revenue, 2017-2028
6.6.2 By Region - Asia Passive Transdermal Drug Delivery Sales, 2017-2028
6.6.3 China Passive Transdermal Drug Delivery Market Size, 2017-2028
6.6.4 Japan Passive Transdermal Drug Delivery Market Size, 2017-2028
6.6.5 South Korea Passive Transdermal Drug Delivery Market Size, 2017-2028
6.6.6 Southeast Asia Passive Transdermal Drug Delivery Market Size, 2017-2028
6.6.7 India Passive Transdermal Drug Delivery Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Passive Transdermal Drug Delivery Revenue, 2017-2028
6.7.2 By Country - South America Passive Transdermal Drug Delivery Sales, 2017-2028
6.7.3 Brazil Passive Transdermal Drug Delivery Market Size, 2017-2028
6.7.4 Argentina Passive Transdermal Drug Delivery Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Passive Transdermal Drug Delivery Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Passive Transdermal Drug Delivery Sales, 2017-2028
6.8.3 Turkey Passive Transdermal Drug Delivery Market Size, 2017-2028
6.8.4 Israel Passive Transdermal Drug Delivery Market Size, 2017-2028
6.8.5 Saudi Arabia Passive Transdermal Drug Delivery Market Size, 2017-2028
6.8.6 UAE Passive Transdermal Drug Delivery Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 3M
7.1.1 3M Corporate Summary
7.1.2 3M Business Overview
7.1.3 3M Passive Transdermal Drug Delivery Major Product Offerings
7.1.4 3M Passive Transdermal Drug Delivery Sales and Revenue in Global (2017-2022)
7.1.5 3M Key News
7.2 Actavis, Inc.
7.2.1 Actavis, Inc. Corporate Summary
7.2.2 Actavis, Inc. Business Overview
7.2.3 Actavis, Inc. Passive Transdermal Drug Delivery Major Product Offerings
7.2.4 Actavis, Inc. Passive Transdermal Drug Delivery Sales and Revenue in Global (2017-2022)
7.2.5 Actavis, Inc. Key News
7.3 Bayer AG
7.3.1 Bayer AG Corporate Summary
7.3.2 Bayer AG Business Overview
7.3.3 Bayer AG Passive Transdermal Drug Delivery Major Product Offerings
7.3.4 Bayer AG Passive Transdermal Drug Delivery Sales and Revenue in Global (2017-2022)
7.3.5 Bayer AG Key News
7.4 Boehringer Ingelheim GmbH
7.4.1 Boehringer Ingelheim GmbH Corporate Summary
7.4.2 Boehringer Ingelheim GmbH Business Overview
7.4.3 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Major Product Offerings
7.4.4 Boehringer Ingelheim GmbH Passive Transdermal Drug Delivery Sales and Revenue in Global (2017-2022)
7.4.5 Boehringer Ingelheim GmbH Key News
7.5 Corium International, Inc.
7.5.1 Corium International, Inc. Corporate Summary
7.5.2 Corium International, Inc. Business Overview
7.5.3 Corium International, Inc. Passive Transdermal Drug Delivery Major Product Offerings
7.5.4 Corium International, Inc. Passive Transdermal Drug Delivery Sales and Revenue in Global (2017-2022)
7.5.5 Corium International, Inc. Key News
7.6 Echo Therapeutics, Inc.
7.6.1 Echo Therapeutics, Inc. Corporate Summary
7.6.2 Echo Therapeutics, Inc. Business Overview
7.6.3 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Major Product Offerings
7.6.4 Echo Therapeutics, Inc. Passive Transdermal Drug Delivery Sales and Revenue in Global (2017-2022)
7.6.5 Echo Therapeutics, Inc. Key News
7.7 GlaxoSmithKline plc
7.7.1 GlaxoSmithKline plc Corporate Summary
7.7.2 GlaxoSmithKline plc Business Overview
7.7.3 GlaxoSmithKline plc Passive Transdermal Drug Delivery Major Product Offerings
7.7.4 GlaxoSmithKline plc Passive Transdermal Drug Delivery Sales and Revenue in Global (2017-2022)
7.7.5 GlaxoSmithKline plc Key News
7.8 Johnson & Johnson (Janssen Pharmaceuticals Inc.)
7.8.1 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Corporate Summary
7.8.2 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Business Overview
7.8.3 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Major Product Offerings
7.8.4 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Passive Transdermal Drug Delivery Sales and Revenue in Global (2017-2022)
7.8.5 Johnson & Johnson (Janssen Pharmaceuticals Inc.) Key News
7.9 Mylan N.V.
7.9.1 Mylan N.V. Corporate Summary
7.9.2 Mylan N.V. Business Overview
7.9.3 Mylan N.V. Passive Transdermal Drug Delivery Major Product Offerings
7.9.4 Mylan N.V. Passive Transdermal Drug Delivery Sales and Revenue in Global (2017-2022)
7.9.5 Mylan N.V. Key News
7.10 Novartis AG
7.10.1 Novartis AG Corporate Summary
7.10.2 Novartis AG Business Overview
7.10.3 Novartis AG Passive Transdermal Drug Delivery Major Product Offerings
7.10.4 Novartis AG Passive Transdermal Drug Delivery Sales and Revenue in Global (2017-2022)
7.10.5 Novartis AG Key News
7.11 Noven Pharmaceuticals, Inc.
7.11.1 Noven Pharmaceuticals, Inc. Corporate Summary
7.11.2 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Business Overview
7.11.3 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Major Product Offerings
7.11.4 Noven Pharmaceuticals, Inc. Passive Transdermal Drug Delivery Sales and Revenue in Global (2017-2022)
7.11.5 Noven Pharmaceuticals, Inc. Key News
7.12 Transdermal Corp.
7.12.1 Transdermal Corp. Corporate Summary
7.12.2 Transdermal Corp. Passive Transdermal Drug Delivery Business Overview
7.12.3 Transdermal Corp. Passive Transdermal Drug Delivery Major Product Offerings
7.12.4 Transdermal Corp. Passive Transdermal Drug Delivery Sales and Revenue in Global (2017-2022)
7.12.5 Transdermal Corp. Key News
8 Global Passive Transdermal Drug Delivery Production Capacity, Analysis
8.1 Global Passive Transdermal Drug Delivery Production Capacity, 2017-2028
8.2 Passive Transdermal Drug Delivery Production Capacity of Key Manufacturers in Global Market
8.3 Global Passive Transdermal Drug Delivery Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Passive Transdermal Drug Delivery Supply Chain Analysis
10.1 Passive Transdermal Drug Delivery Industry Value Chain
10.2 Passive Transdermal Drug Delivery Upstream Market
10.3 Passive Transdermal Drug Delivery Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Passive Transdermal Drug Delivery Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
